Clinical Trials Logo

Asthma clinical trials

View clinical trials related to Asthma.

Filter by:

NCT ID: NCT04912596 Recruiting - Mild Asthma Clinical Trials

Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the pharmacodynamic (PD) bioequivalence (BE) of albuterol inhalers, test formulation: Albuterol Sulfate HFA inhalation aerosol 108 mcg (equal to albuterol base 90 mcg) per actuation and reference formulation: ProAir HFA (albuterol sulfate) or FDA authorized generic: Albuterol Sulfate HFA (Teva Pharmaceutical USA, Inc.) Inhalation Aerosol 108 mcg (equal to albuterol base 90 mcg) per actuation manufactured by two different manufacturers using methacholine bronchoprovocation challenge test in patients with stable mild asthma.

NCT ID: NCT04908384 Completed - Asthma in Children Clinical Trials

Improving Asthma Care Together (IMPACT): A Shared Management Pilot Study

IMPACT
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This study aims to iteratively develop, refine and test the Improving Asthma Care Together (IMPACT) Intervention for school-age children (7-11 years) with persistent asthma and their parents.

NCT ID: NCT04905602 Recruiting - Asthma Clinical Trials

A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma

Start date: June 15, 2021
Phase: Phase 1
Study type: Interventional

This study is a phase 1 single dose escalation study of SHR-1905 in healthy subjects and subjects with mild asthma. The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics of SHR-1905 in healthy subjects and subjects with mild asthma.

NCT ID: NCT04905420 Completed - Asthma Clinical Trials

The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients

PCCM-IMPACTS
Start date: December 8, 2021
Phase:
Study type: Observational

A Multi-centre, retrospective study describing the impact of PCCM standardized implementation on healthcare management among Asthma or COPD or Asthma-COPD overlap patients in Tianjin city of China, using real world electronic medical record database collected in local health care settings.

NCT ID: NCT04903145 Not yet recruiting - Asthma in Children Clinical Trials

Proof-of-concept of the Measurement of Lung Function Using the Relaxed Expiratory Occlusion Monitor (REOM)

Start date: June 2021
Phase:
Study type: Observational

(i) To validate the inversed occlusion technique by comparing the results of resistance obtained on the relaxed expiratory occlusion monitor (REOM) with the resistance obtained with respiratory oscillometry (OSC) measurements on the tremoflo® C-100 and (ii) explore (within-test and day-to-day) repeatability and responsiveness to change of this technique when used as home monitoring device in children with asthma.

NCT ID: NCT04902573 Active, not recruiting - Asthma Clinical Trials

A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes

TriMaximize
Start date: June 17, 2021
Phase:
Study type: Observational

TriMaximize, a non-interventional trial aims to collect prospective, longitudinal data from asthma patients under routine care, for whom their treating physician has decided to prescribe Trimbow® (beclometasone/formoterol/glycopyrronium).

NCT ID: NCT04901260 Completed - Asthma Clinical Trials

AMAZE™ Asthma Implementation QI Study

Start date: November 25, 2020
Phase:
Study type: Observational

The primary study objective is to generate evidence as to the feasibility, usability, perceived value, and potential benefits of implementing the AMAZE™ platform into clinical practice.

NCT ID: NCT04898283 Recruiting - Rhinoconjunctivitis Clinical Trials

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

Start date: May 31, 2021
Phase: Phase 3
Study type: Interventional

A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis With or Without Mild to Moderate Asthma Sensitized to cupressaceae and grasses.

NCT ID: NCT04896645 Completed - Asthma in Children Clinical Trials

Albuterol Integrated Adherence Monitoring in Children With Asthma

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The investigators propose to evaluate whether an integrated electronic adherence monitoring albuterol rescue inhaler can improve proper use in a mostly minority and inner-city population of children treated for asthma at the Children's Hospital of Los Angeles

NCT ID: NCT04896502 Completed - Asthma in Children Clinical Trials

Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers

Start date: September 26, 2019
Phase: N/A
Study type: Interventional

The study is about comparing asthma home assessments/interventions by telemedicine compared to providing education alone. Interactive Video (IAV) defines telemedicine. It allows two-way communication in real-time with both audio and visual communication between the subject and someone from the study team. It is similar to using Face Time on a mobile device. Asthma home assessments/interventions are used to identify things in a home that can make asthma symptoms worse, called triggers. Reducing these triggers in the home can improve asthma.